Related Experiment Video
Updated: May 27, 2026

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
Published on: February 2, 2024
Impaired diffusing capacity for carbon monoxide in children with type 1 diabetes: is this the first sign of long-term
Andrea E Scaramuzza1, Marco Morelli, Maurizio Rizzi
1Department of Paediatrics, "Luigi Sacco Hospital", University of Milano, Milan, Italy. scaramuzza.andrea@hsacco.it
Insights
Children with type 1 diabetes show reduced lung diffusing capacity for carbon monoxide (DLCO), specifically in pulmonary capillary blood volume (Vc). This suggests potential microvascular complications, warranting DLCO screening in diabetic children.
Area of Science:
- Pediatric Endocrinology
- Pulmonary Medicine
- Diabetic Complications
Background:
- Type 1 diabetes (T1D) can lead to microvascular complications.
- Lung dysfunction, particularly reduced diffusing capacity of the lung for carbon monoxide (DLCO), is a potential complication.
- Understanding early lung changes in T1D is crucial for timely intervention.
Purpose of the Study:
- To assess lung dysfunction in children with T1D.
- To evaluate the components of DLCO: membrane diffusing capacity (DM) and pulmonary capillary blood volume (Vc).
- To investigate potential early microangiopathic changes in the lungs of T1D patients.
Main Methods:
- Recruited 42 children with T1D and 30 healthy controls.
- Assessed lung volumes and spirometry using plethysmography.
- Measured single-breath DLCO and calculated DM and Vc.
Main Results:
- Children with T1D had reduced lung volumes compared to controls.
- Overall DLCO was significantly lower in T1D patients (78% ± 16%) versus controls (120% ± 1%).
- Impairment was specifically noted in Vc (34 ± 20 ml vs. 88 ± 18 ml), while DM showed no significant difference.
Conclusions:
- Reduced Vc in T1D children may indicate early microangiopathic changes.
- DLCO impairment, particularly Vc, could be an early sign of lung involvement in T1D.
- Screening DLCO in all patients with type 1 diabetes is recommended.
Abstract:
We assessed the presence of lung dysfunction in children with type 1 diabetes, evaluated as reduced diffusing capacity of the lung for carbon monoxide (DLCO), and its components: membrane diffusing capacity (DM) and pulmonary capillary blood volume (Vc). A total of 42 children, aged 15.6 ± 3.8 years, with type 1 diabetes for 8.3 ± 5.5 years, and 30 healthy age and sex-matched peers were recruited for the study. Lung volumes and spirometric dynamic parameters were assessed by plethysmography. Single-breath DLCO was measured according to international recommendation. DM and Vc volume were calculated. Lung volumes were significantly reduced in young patients with type 1 diabetes when compared to controls. Moreover, DLCO was reduced in patients compared to controls (78% ± 16% vs. 120% ± 1%, P = 0.0001). However, when differentiating DM and Vc compartments, we observed a significant impairment only about Vc (34 ± 20 ml vs. 88 ± 18 ml; P = 0.0001), while no difference was observed about DM compartment (23 ± 4 vs. 26 ± 3 ml/min/mmHg, P = 0.798). Whether this might be seen as the "first" sign of microangiopathic involvement in patients with type 1 diabetes has to be confirmed on larger groups but is still fascinating. Meanwhile, we suggest to screen DLCO in all patients with type 1 diabetes.
More Related Videos
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Complications of Diabetes Mellitus
Diabetic Ketoacidosis l: Introduction
Type I Diabetes III: Clinical Manifestations
Type I Diabetes I: Introduction
Diabetic Retinopathy

